Financial Advisors Network Inc. Invests $229,000 in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Financial Advisors Network Inc. purchased a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 8,781 shares of the pharmacy operator’s stock, valued at approximately $229,000.

A number of other institutional investors and hedge funds have also made changes to their positions in WBA. New York Life Investment Management LLC boosted its holdings in Walgreens Boots Alliance by 0.4% during the third quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock worth $2,547,000 after buying an additional 499 shares in the last quarter. Fulton Bank N.A. lifted its holdings in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after purchasing an additional 523 shares in the last quarter. Insight Folios Inc lifted its holdings in shares of Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after purchasing an additional 525 shares in the last quarter. Pinnacle Financial Partners Inc lifted its holdings in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after purchasing an additional 555 shares in the last quarter. Finally, Westpac Banking Corp lifted its holdings in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after purchasing an additional 560 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Manmohan Mahajan purchased 6,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Wall Street Analysts Forecast Growth

WBA has been the subject of a number of analyst reports. Bank of America cut their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research report on Tuesday, March 26th. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating for the company in a report on Wednesday, April 3rd. UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Wednesday, April 3rd. Finally, SVB Leerink decreased their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a report on Monday, March 18th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $24.36.

Check Out Our Latest Stock Report on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Down 1.6 %

WBA traded down $0.26 during trading on Thursday, hitting $16.21. The company’s stock had a trading volume of 5,000,191 shares, compared to its average volume of 13,022,583. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a twelve month low of $16.13 and a twelve month high of $32.89. The stock’s fifty day moving average price is $18.65 and its 200-day moving average price is $21.23. The firm has a market capitalization of $13.98 billion, a P/E ratio of -2.31, a PEG ratio of 1.03 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.16 EPS. Analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 6.17%. Walgreens Boots Alliance’s payout ratio is -14.29%.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Further Reading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.